AUA. B.. Utkina

A. B.. Utkina

*This is an algorithmically generated author record based on publicly available information.

A. B.. Utkina has a total of 29 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • An example of successful combination treatment of a patient with primary multiple synchronous squamous cell carcinoma of the esophagus and squamous cell carcinoma of the stomach

    by A.B. Utkina, V.M. Khomyakov, I.V. Kolobaev, O.S. Kuznetsova, A.B. Ryabov

    Our work presents an extremely rare case of primary synchronous tumors in the esophagus and stomach with a similar histological type, with a different approach to treatment in a young patient. The high sensitivity of squamous cell carcinoma to drug therapy was vividly reflected in our example and clinically proven in the form of complete tumor resorption in the esophagus. Despite the generally accepted standards of treatment, we were dictated an individual treatment plan, thanks to which we managed to limit ourselves to gastric surgery, thereby avoiding the extended resection stage on the esophagus, thereby maintaining an optimal quality of life.

  • Possibilities of laparoscopic surgery in the treatment of patients with retroperitoneal tumors

    by A.B. Ryabov, V.M. Khomyakov, D.D. Sobolev, I.V. Kolobaev, N.V. Vorobyev, N.M. Abdulkhakimov, A.V. Chaika, K.I. Salimzyanov, A.A. Krasheninnikov, A.B. Utkina, et al.

    Today, radical surgical intervention is still one of the main methods of treatment for the majority of non-organ tumors in the retroperitoneal space. The rapid development of minimally invasive surgery in the last 10 years has been accompanied by an increase in the number of publications devoted to laparoscopic surgery of retroperitoneal formations. Minimally invasive surgery is a safe and technically feasible alternative to traumatic laparotomy access for localized tumors. The article presents a series of clinical observations and a review of the literature on this problem. Further accumulation of experience in performing this type of surgery and follow-up of these patients will make it possible to evaluate the long-term results and form criteria for selecting patients for minimally invasive treatment.

  • Open Access

    Treatment outcomes in young adults with gastric cancer

    by D. M. Pugaev, A. B. Ryabov, V. M. Khomyakov, I. V. Kolobaev, A. K. Kostrygin, O. A. Aleksandrov, G. S. Pogosуan, D. D. Sobolev, A. V. Chayka, A. B. Utkina, et al.

    Introduction. According to global data, gastric cancer (GC) is the 5-th most common malignancy with a high cancer-related mortality rate. However, in recent decades, there has been a tendency towards an increase in the incidence of GC among young patients (18 to 40 years old), which currently amounts to 4.4–9.8%. Aim: to evaluate the effectiveness of surgical, combined and palliative treatment options in early-onset GC. Material and Methods. the study included 129 patients aged 18–45 years, who underwent radical, cytoreductive and palliative surgery with or without combination with drug therapy for localized, locally-advanced and primary disseminated GC. the patients were divided into three clinical groups: 1) the surgical group (n=27) included patients with only surgical treatment; 2) the group of combined treatment (n= 58) included patients with PCI 7 who underwent systemic CT in combination with pressurized intraperitoneal aerosol chemotherapy (PIPAC). Results. the median overall survival (OS) in three groups was 58, 30 and 13 months, respectively. In patients with IV stage of disease who underwent HIPEC with CC0 surgery, OS in the 2nd group was 17 in comparison with 13 months in the third group (PIPEC). Conclusion. Aggressive multimodal treatment in the absence of comorbid status in young patients will allow for intensification of both the perioperative drug therapy component and the implementation of extended multivisceral resections that facilitate radical surgical treatment to improve both DFS and OS.

  • Open Access

    Nephronsparing surgery for retroperitoneal sarcomas

    by A. B. Ryabov, A. V. Chaika, V. M. Khomyakov, О. А. Александров, A. K. Kostrygin, D. D. Sobolev, G. S. Pogosyan, S. V. Arzumanov, N. V. Vorobyov, V. V. Cheremisov, et al.

    Objective: to clarify the indications for the use of nephron-sparing technologies in surgical treatment of patients with retroperitoneal sarcomas. Material and Methods. The study included 64 patients with primary retroperitoneal sarcomas with kidney and renal pedicle invasion, who underwent surgical treatment in the Thoracic-abdominal Department of the P.A. Herzen Moscow Oncology Research Institute from 2010 to 2021. Twenty-one patients underwent nephrectomies, and 43 patients underwent nephron-sparing surgery. The morphological profile of sarcomas, age and gender of the patients, feasibility of using nephron-sparing technologies, postoperative complications, and long-term outcomes in patients of both groups were analyzed. Results. Forty-three patients with primary retroperitoneal sarcomas with invasion of the renal parenchyma, ureter, and renal pedicle underwent nephron-sparing surgery (precision mobilization of the kidney, ureter and vascular structures of the kidney from tumor tissue, kidney resection, ureteral stenting, resection of the renal vein orifices, resection of the ureters, and kidney autotransplantation). Postoperative complications were observed in 19.0 % of nephrectomy group patients (4 pts: II, IIIB, IV and V types according to Clavien–Dindo) and in 30.2 % of nephron-sparing group patients (15 pts: types II – 8, IIIA – 1, IIIB – 3, IV – 1). No statistical differences in the relapse-free period and survival time between two groups were observed. The 1-, 3- and 5-year survival rates were 84.1 %, 65.9 %, and 51.4 %, respectively. Multifactorial analysis showed that mortality increased significantly in patients over 64 years of age and was associated with both disease recurrence and concomitant pathology (p=0.009). There was also a trend toward decreased survival in patients with leiomyosarcoma (p=0.066). Conclusion. In retroperitoneal sarcomas, tumor resection with preservation of organs and structures not directly invaded by the tumor is the optimal surgical strategy. Nephron-sparing technologies do not worsen both immediate and long-term treatment outcomes. For leiomyosarcoma, tumor resection with nephrectomy is the most suitable approach.

  • Experience of successful treatment of leaks of high esophageal-intestinal anastomoses after gastrectomy by means of video-assisted thoracoscopic debridement and cycles of vacuum active aspiration system

    by A.B. Utkina, A.B. Ryabov, V.M. Khomyakov, O.V. Pikin, I.V. Kolobaev, L.Y. Grivtsova, O.A. Politico

    The article presents clinical observations of 2 patients after perioperative polychemotherapy, who, as part of combined treatment, underwent extended resection stages in the form of gastrectomy with the formation of a high esophago-intestinal anastomosis in the mediastinum. During observations after the diagnosis of anastomosis failure, in order to separate the lumen of the defect zone from the pleural cavity, it was necessary to conduct a single thoracoscopic sanitation and program cycles of the vacuum aspiration system, thereby eliminating the complication and eliminating the possibility of extirpation of the previously formed reconstruction.

  • Pressurized intraperitoneal aerosol chemotherapy in combination with cytoreductive surgery in patients with gastric cancer and limited peritoneal carcinomatosis

    by S.A. Aksenov, V.M. Khomyakov, A.B. Ryabov, I.V. Kolobaev, D.D. Sobolev, O.S. Kuznetsova, A.B. Utkina, N.M. Abdulkhakimov, K.I. Salimzyanov, A.V. Chayka, et al.

    Cytoreductive surgery in combination with preoperative chemotherapy (also known as conversion surgery) is a promising treatment option for patients with limited peritoneal carcinomatosis. Local chemotherapy combined with cytoreductive procedures is widely discussed in literature as preventive approach for intraoperative dissemination. Objective. To This study aimed to evaluate the safety and efficacy of Pressurized Intraperitoneal Aerosol Chemotherapy (PIPAC) in combination with cytoreductive surgery for patients with gastric cancer and limited peritoneal carcinomatosis (PCI < 7). Material and methods. Between 2019 and 2023, in total 20 patients with gastric cancer and limited peritoneal carcinomatosis underwent cytoreductive surgeries combined with PIPAC session at the NMIC of Radiology, Ministry of Health, Russian Federation. Results. Of the 21 patients, 3 (31.1%) had a partial response, in 17 patients primary tumor stabilization was observed after preoperative treatment, in 10 patients (50%), a complete response of peritoneal metastasis was achieved. All patients underwent complete cytoreduction (R0/CC-0). Major pathological response of the primary tumor was achived in 2 (10%) patients — TRG1a per Becker and in 4 (20%) — TRG1b per Becker, TRG2 and TRG3 in 5 (25%) and 9 (45%) patients, respectively. The median overall survival was 27 months and the disease-free survival was 7 months. 1-year and 2-year overall survival rates were 95% and 60%, respectively. Conclusion. Cytoreductive surgery in combination with PIPAC is feasible and safe. The survival rates demonstrate the potential effectiveness of this method. However, in order to make a clear assessment of the efficacy of adjuvant intraperitoneal chemotherapy as an approach for preventing intraoperative dissemination during cytoreductions, further randomized controlled trials is needed.


  • Conversion surgery for gastric cancer with limited peritoneal carcinomatosis

    by S.A. Aksenov, V.M. Khomyakov, A.B. Ryabov, I.V. Kolobaev, D.D. Sobolev, A.B. Utkina, K.I. Salimzyanov, A.K. Kostrygin, A.V. Chayka, A.D. Kaprin

    Conversion surgery for disseminated gastric cancer is attracting increasing attention as a new therapeutic strategy. A number of European and Asian studies on this topic have presented data on the advantage of performing cytoreductive surgery in a limited group of patients. Objective. To evaluate the safety and efficacy of conversion surgery for gastric cancer with limited peritoneal carcinomatosis. Material and methods. In the period from 2015 to 2022, 45 cytoreductive surgical interventions in patients with limited peritoneal carcinomatosis (PCI ≤7) in gastric cancer were performed in National Medical Radiology Research Center. Results. After preoperative drug treatment, 24 cases showed complete regression of carcinomatosis foci confirmed histologically and cytologically, while the remaining cases achieved partial response or stabilization. Surgical intervention was supplemented with hyperthermic intraoperative intra-abdominal chemotherapy or sessions of intra-abdominal aerosol chemotherapy. The extent of cytoreduction was considered as R0/CC-0 in 38 (84%) of 45 patients. Median overall survival was 24.1 months, with overall one- and two-year survival rates of 84.4 and 52%, respectively. Conclusion. Analysis of the results of conversion surgery for gastric cancer with limited peritoneal carcinomatosis has demonstrated the safety and efficacy of this approach with careful selection of patients. Further recruitment and analysis of the accumulated experience will make it possible to clarify the criteria for selecting patients for conversion surgery, as well as the optimal regimens of perioperative drug treatment.

  • Experience of prolonged palliative treatment in a patient with signet ring cell gastric cancer with peritoneal recurrence and metastases to the ovaries after prior gastrectomy

    by A.B. Utkina, V.M. Khomyakov, D.D. Sobolev, L.V. Bolotina, A.B. Ryabov

    This article presents a clinical case of treating a 39-year-old female patient with disseminated gastric cancer after combined treatment with peritoneal carcinomatosis and ovarian metastases. The patient underwent two lines of systemic polychemotherapy and immunotherapy combined with sessions of intraperitoneal aerosol chemotherapy. The observation period exceeded 30 months.

  • Open Access

    Transhiatal laparoscopic enucleation of lower thoracic esophageal leiomyoma

    by A. B. Ryabov, V. M. Khomyakov, N. N. Volchenko, I. V. Kolobaev, A. K. Kostrygin, D. D. Sobolev, A. B. Utkina, S. A. Aksenov, M. P. Makurina

    The purpose of the study. Mesenchymal tumors of the esophagus comprise 2 % of all esophageal tumors. Leiomyosarcoma is the most common mesenchymal tumor in the esophagus (up to 80 %). It is located in the lower third of the esophagus. The main treatment modality of leiomyosarcoma is surgery. Due to the low frequency of occurrence, there are no unified approaches to the choice of surgical volume and access. Minimally invasive techniques have advantages over open approaches. However, final treatment approach depends on many factors: localization and location of the tumor around the circumference of the esophagus, as well as size. Endoscopic resection is feasible for small tumors with an intramural growth. In case of large leiomyomas, Lewis operation should be performed. In all other cases, tumor enucleation is the gold standard of treatment. The issue of minimally invasive surgical access is relevant. Thoracoscopic access has limitations for tumors located in the lower thoracic esophagus closer to the esophageal-gastric junction. In this regard, a laparoscopic approach with the possibility of transhiatal mobilization of the esophagus provides an adequate opportunity for tumor enucleation.Clinical case description. We hereby report our case study in which we employ the use of laparoscopic transhiatal enucleation to remove leiomyoma of the lower thoracic part of the esophagus. A 47-year-old female presented to P.A. Herzen Moscow Oncology Research Institute with complaints of pain in the epigastrium, discomfort behind the sternum when taking solid food. R0 resection was performed. During the one year follow-up period no sign of disease recurrence was observed.Conclusion. This approach, in our opinion, is fully justified, with careful selection of patients and compliance with guidelines of cancer surgery. Laparoscopic approach with transhiatal mobilization of the esophagus provides a good opportunity to perform the enucleation of mesenchymal tumors localized in the lower third of the thoracic region, at the level of the supraphrenic and abdominal segments.

  • Results of systemic chemotherapy in combination with pressurized intraperitoneal aerosol chemotherapy in patients with gastric cancer and synchronous peritoneal carcinomatosis

    by V.M. Khomyakov, A.B. Ryabov, A.B. Utkina, D.D. Sobolev, A.V. Chayka, A.K. Kostrygin, S.A. Aksenov, L.V. Bolotina, O.S. Kuznetsova, A.D. Kaprin